Johnson & Johnson Medical Inc.
Division of Johnson & Johnson
Latest From Johnson & Johnson Medical Inc.
Endo International announced plans this week to pay $775m to settle 22,000 US claims. Meanwhile, J&J is launching its sixth mesh lawsuit in Philadelphia and questioning jurisdiction.
Medtronic may be looking to buy the British orthopedics device company in part so that it can move its home to the UK for tax purposes, according to a report from Bloomberg. But Securities analysts report that the rumored deal probably does not make sense for Medtronic.
Boston Scientific aims to increase revenue from emerging markets to 15% by 2017 from its current 9%. Executive Vice President Supratim Bose unveiled the ambition during a recent media roundtable and named China as the most important market for the company.
DePuy settles bulk of U.S. ASR suits. Tandem Diabetes closes $138 million IPO. AtriCure gets go-ahead for new AtriClip stroke. More news.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.